{
    "clinical_study": {
        "@rank": "143049", 
        "arm_group": [
            {
                "arm_group_label": "NuCel", 
                "arm_group_type": "Experimental", 
                "description": "Stemcell allograft"
            }, 
            {
                "arm_group_label": "DBX", 
                "arm_group_type": "Active Comparator", 
                "description": "DBM bone graft substitute"
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of this study is to compare the effect and safety of NuCel to DBX on patients\n      undergoing posteriolateral lumbar spinal fusions for degenerative disc disease."
        }, 
        "brief_title": "Efficacy of a Human Amniotic Tissue-derived Allograft, NuCel, in Patients Undergoing Posteriolateral Lumbar Fusions for Degenerative Disc Disease", 
        "completion_date": {
            "#text": "February 2016", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Lumbar Degenerative Disc Disease", 
            "Spinal Stenosis", 
            "Spondylolisthesis", 
            "Spondylosis", 
            "Intervertebral Disk Displacement", 
            "Intervertebral Disk Degeneration", 
            "Spinal Diseases", 
            "Bone Diseases", 
            "Musculoskeletal Diseases", 
            "Spondylolysis"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Bone Diseases", 
                "Spinal Diseases", 
                "Intervertebral Disk Displacement", 
                "Musculoskeletal Diseases", 
                "Spinal Stenosis", 
                "Spondylolisthesis", 
                "Spondylolysis", 
                "Spondylosis", 
                "Intervertebral Disk Degeneration"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Between the ages of 18 and 75 years\n\n          -  Symptomatic, single-level degenerative lumbar disc disease, spondylosis or\n             spondylolisthesis\n\n          -  Failed conservative treatments\n\n          -  Low risk for non-union\n\n          -  Must be candidates for single-level, posteriolateral lumbar spine fusion\n\n          -  Must be able and willing to give Informed Consent\n\n          -  English-speaking\n\n        Exclusion Criteria:\n\n          -  Smoker (any smoking \u22643 months prior to consent); (Patel et al. 2013)\n\n          -  Patients with poorly controlled diabetes mellitus (HgbA1c > 7%)\n\n          -  Documented osteoporosis\n\n          -  Prior lumbar spinal surgery at the same spinal level, or immediately adjacent spine\n             level, to the level being operated on\n\n          -  Back pain due to infection, tumour, or metabolic bone disease\n\n          -  Terminal disease, such as HIV infection, neoplasm\n\n          -  Autoimmune disease, such as rheumatoid arthritis\n\n          -  Morbid obesity (body mass index (BMI) of 35 kg/m2)\n\n          -  Major psychiatric illness in the last year\n\n          -  History of alcohol or drug abuse in the last year\n\n          -  Pregnant women"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "75 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "60", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "February 21, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02070484", 
            "org_study_id": "OH2-13-0034"
        }, 
        "intervention": [
            {
                "arm_group_label": "NuCel", 
                "intervention_name": "NuCel", 
                "intervention_type": "Biological"
            }, 
            {
                "arm_group_label": "DBX", 
                "intervention_name": "Deminaralized Bone Matrix", 
                "intervention_type": "Biological"
            }
        ], 
        "is_fda_regulated": "No", 
        "keyword": [
            "NuCel", 
            "Lumbar Spine", 
            "Degenerative Disease", 
            "Efficacy", 
            "Fusion"
        ], 
        "lastchanged_date": "April 15, 2014", 
        "location": {
            "contact": {
                "email": "lauren.allison@ohiohealth.com", 
                "last_name": "Lauren Allison, BSN, RN, CCRC", 
                "phone": "6145668394"
            }, 
            "facility": {
                "address": {
                    "city": "Columbus", 
                    "country": "United States", 
                    "state": "Ohio", 
                    "zip": "43215"
                }, 
                "name": "Grant Medical Center"
            }, 
            "investigator": {
                "last_name": "Joseph Shehadi, MD", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "2", 
        "official_title": "Efficacy of a Human Amniotic Tissue-derived Allograft, NuCel, in Patients Undergoing Posteriolateral Lumbar Fusions for Degenerative Disc Disease", 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United States: OhioHealth Research and Innovation Institute Office of Regulatory Compliance", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "February 2016", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Oswestry Disability Index", 
            "safety_issue": "No", 
            "time_frame": "12 months"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02070484"
        }, 
        "responsible_party": {
            "investigator_affiliation": "OhioHealth", 
            "investigator_full_name": "Joseph A. Shehadi, MD", 
            "investigator_title": "Principal Investigator", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": {
            "measure": "Radiological", 
            "safety_issue": "No", 
            "time_frame": "12 months"
        }, 
        "source": "OhioHealth", 
        "sponsors": {
            "collaborator": {
                "agency": "NuTech Medical, Inc.", 
                "agency_class": "Other"
            }, 
            "lead_sponsor": {
                "agency": "OhioHealth", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "February 2014", 
        "study_design": "Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Single Blind (Subject), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "April 2014"
    }
}